Ascendis Pharma A/S - 存托凭证(普通股) - 收益表 (TTM)

Ascendis Pharma A/S - 存托凭证(普通股)
MX ˙ BMV ˙ US04351P1012
收益表 (TTM)

Ascendis Pharma A/S - 存托凭证(普通股) 损益表显示一段时间内收入和支出的变化。损益表数据包括销售和收入、毛利、研发、销售、一般和管理费用、经营收入、所得税费用、利息费用、营业外收入、每股收益和已发行股票。

除每股单位外,所有数字都是 1,000,000。

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
收入 9 7 5 5 3 8 14 19 33 51 78 119 152 267 329 318 327 364 369 491
改变 (%) -22.10 -21.27 -7.58 -32.48 127.69 78.19 37.08 74.61 54.25 52.29 52.91 27.48 75.57 23.36 -3.46 3.09 11.06 1.39 33.10
收入百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
销售成本 185 -58 -121 -185 4 8 9 11 12 13 24 30 44 47 46 50 44 54 74
改变 (%) 110.54 52.90 -101.90 120.52 13.98 19.12 15.06 3.09 94.66 23.38 47.74 6.64 -3.09 8.31 -10.94 22.48 36.86
收入百分比 2,074.53 -1,050.69 -2,393.62 -5,420.14 45.29 56.05 46.61 31.80 23.72 16.05 20.44 19.78 16.64 14.39 14.44 15.18 12.17 14.70 15.12
毛营业利润 -176 7 63 126 189 4 6 10 23 39 65 95 122 222 282 272 278 319 314 417
改变 (%) -103.95 805.93 100.28 49.48 -97.74 43.15 66.54 123.06 72.52 67.59 44.92 28.53 82.44 26.70 -3.53 2.20 15.00 -1.53 32.45
收入百分比 -1,974.53 100.00 1,150.69 2,493.62 5,520.14 54.71 43.95 53.39 68.20 76.28 83.95 79.56 80.22 83.36 85.61 85.56 84.82 87.83 85.30 84.88
销售、一般及行政费用 73 77 96 111 132 160 170 192 213 221 240 254 257 264 265 269 275 291 325 359
改变 (%) 4.57 25.21 15.14 19.69 21.07 6.35 12.47 11.16 3.87 8.64 5.70 1.16 2.89 0.09 1.52 2.31 5.91 11.77 10.22
收入百分比 821.51 1,102.68 1,753.76 2,185.02 3,873.01 2,059.40 1,229.08 1,008.43 641.99 432.30 308.40 213.18 169.17 99.13 80.44 84.59 83.96 80.06 88.26 73.08
研发 50 261 349 432 491 296 291 298 337 380 403 417 431 413 378 356 319 307 323 311
改变 (%) 418.92 33.79 23.87 13.59 -39.76 -1.68 2.43 12.98 12.76 6.04 3.64 3.36 -4.11 -8.57 -5.70 -10.63 -3.64 5.18 -3.56
收入百分比 563.34 3,752.39 6,376.56 8,546.33 14,377.05 3,803.90 2,098.92 1,568.44 1,014.79 741.83 516.51 350.08 283.84 155.02 114.89 112.23 97.30 84.43 87.58 63.46
运营支出 309 338 388 422 438 460 469 498 560 613 655 696 718 722 690 671 643 642 703 744
改变 (%) 9.34 14.80 8.84 3.90 4.86 2.06 6.27 12.39 9.43 6.92 6.13 3.26 0.56 -4.46 -2.75 -4.15 -0.12 9.36 5.94
收入百分比 3,459.38 4,855.07 7,079.63 8,337.73 12,829.92 5,908.59 3,384.06 2,623.47 1,688.57 1,197.85 840.96 583.70 472.79 270.79 209.72 211.27 196.44 176.66 190.54 151.66
营业收入 -300 -331 -382 -417 -435 -452 -455 -479 -527 -562 -577 -576 -566 -456 -361 -353 -316 -279 -334 -254
改变 (%) 10.27 15.56 9.08 4.34 3.90 0.75 5.33 9.92 6.60 2.79 -0.18 -1.75 -19.56 -20.75 -2.10 -10.66 -11.72 19.75 -24.06
收入百分比 -3,359.38 -4,755.07 -6,979.63 -8,237.73 -12,729.92 -5,808.59 -3,284.06 -2,523.47 -1,588.57 -1,097.85 -740.96 -483.70 -372.79 -170.79 -109.72 -111.27 -96.44 -76.66 -90.54 -51.66
利息花费 -59 -2 -2 -3 -4 -25 -17 -27 -31 -39 -35 -41 -44 -136 -133 -110 -66 -33 -85
改变 (%) -96.77 22.00 17.31 537.56 -31.66 56.75 14.86 28.16 -12.26 18.67 7.63 208.84 -2.21 -17.51 -40.33 -49.42 155.83
收入百分比 -665.01 -27.59 -42.75 -54.26 -50.28 -179.91 -89.69 -80.52 -59.96 -50.46 -28.95 -26.95 -16.52 -41.36 -41.90 -33.53 -18.01 -8.99 -17.27
净利 -360 -419 -418 -458 -416 -384 -446 -393 -482 -583 -569 -609 -602 -481 -502 -490 -426 -378 -342 -271
改变 (%) 16.26 -0.13 9.43 -9.04 -7.90 16.35 -11.89 22.53 21.04 -2.50 7.05 -1.11 -20.02 4.18 -2.40 -12.87 -11.35 -9.63 -20.64
收入百分比 -4,037.56 -6,025.53 -7,643.95 -9,050.64 -12,192.04 -4,931.56 -3,219.94 -2,069.74 -1,452.41 -1,139.63 -729.60 -510.81 -396.27 -180.51 -152.44 -154.12 -130.26 -103.97 -92.67 -55.25

Source: Capital IQ

Other Listings
US:ASND US$195.58
DE:A71
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista